Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Jakob R. Passweg"'
Autor:
Yoshiko Atsuta, Helen Baldomero, Daniel Neumann, Anna Sureda, Jakob D. DeVos, Minako Iida, Amado Karduss, Duncan Purtill, Alaa M. Elhaddad, Nosa G. Bazuaye, Carmem Bonfim, Rafael de la Camara, Naeem A. Chaudhri, Fabio Ciceri, Cinthya Correa, Cristobal Frutos, Sebastian Galeano, Laurent Garderet, Oscar Gonzalez-Ramella, Raffaella Greco, Nada Hamad, Mette D. Hazenberg, Mary M. Horowitz, Krzysztof Kalwak, Bor-Sheng Ko, Yoshihisa Kodera, Mickey BC Koh, Kaiyan Liu, Donal P. McLornan, Joon Ho Moon, Benedicte Neven, Shinichiro Okamoto, Marcelo C Pasquini, Jakob R. Passweg, Kristjan Paulson, Damiano Rondelli, Annalisa Ruggeri, Adriana Seber, John A. Snowden, Alok Srivastava, Jeff Szer, Daniel Weisdorf, Nina Worel, Hildegard Greinix, Wael Saber, Mahmoud Aljurf, Dietger Niederwieser
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Promoting access to and excellence in hematopoietic cell transplantation (HCT) by collecting and disseminating data on global HCT activities is one of the principal activities of the Worldwide Network for Blood and Marrow Transplantation, a non-Gover
Externí odkaz:
https://doaj.org/article/dcbc8f7bb65c4274993de5cc2382ba19
Autor:
Dominik Heim, Helen Baldomero, Michael Medinger, Stavroula Masouridi-Levrat, Urs Schanz, Gayathri Nair, Tayfun Güngör, Jörg Halter, Jakob R. Passweg, Yves Chalandon, Swiss Stem Cell Transplantation Group (SBST)
Publikováno v:
Swiss Medical Weekly, Vol 154, Iss 5 (2024)
AIM: Until the year 2000, allogeneic haematopoietic cell transplantation (HCT) was the standard treatment for young and fit chronic myeloid leukaemia (CML) patients. CML was the main indication for allogeneic HCT. The introduction of tyrosine kinase
Externí odkaz:
https://doaj.org/article/e094cf77c51f4bccbbba9ae93266b65f
Autor:
Sarah Jungius, Franziska C. Adam, Kerstin Grosheintz, Michael Medinger, Andreas Buser, Jakob R. Passweg, Jörg P. Halter, Sara C. Meyer
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionMyelofibrosis (MF) is a rare hematopoietic stem cell disorder progressing to bone marrow (BM) failure or blast phase. Allogeneic hematopoietic cell transplantation (HCT) represents a potentially curative therapy for a limited subset of pa
Externí odkaz:
https://doaj.org/article/ab130bbf154f40a89377d4418000d849
Autor:
Damien Luque Paz, Michael S. Bader, Ronny Nienhold, Shivam Rai, Tiago Almeida Fonseca, Jan Stetka, Hui Hao-Shen, Gabriele Mild-Schneider, Jakob R. Passweg, Radek C. Skoda
Publikováno v:
HemaSphere, Vol 7, Iss 5, p e885 (2023)
Myeloproliferative neoplasms (MPNs) are caused by a somatic gain-of-function mutation in 1 of the 3 disease driver genes JAK2, MPL, or CALR. About half of the MPNs patients also carry additional somatic mutations that modify the clinical course. The
Externí odkaz:
https://doaj.org/article/81859577bfc14bcca1747a3f6ad405a3
Autor:
Franziska C. Adam, Jakub Szybinski, Jörg P. Halter, Nathan Cantoni, Friedel Wenzel, Katharina Leonards, Sime Brkic, Jakob R. Passweg, Ivo Touw, Julia E. Maxson, Sara C. Meyer
Publikováno v:
Current Oncology, Vol 29, Iss 2, Pp 805-815 (2022)
Chronic neutrophilic leukemia (CNL) relates to mutational CSF3R activation with membrane proximal CSF3R mutations such as T618I as driver mutations, but the significance of truncating mutations is not clarified. In CNL, concomitant mutations promote
Externí odkaz:
https://doaj.org/article/7c6926b7e08c4f438dc34b200fa1a338
Autor:
Nicolas Fattinger, Jan A. Roth, Helen Baldomero, Daiana Stolz, Michael Medinger, Dominik Heim, Michael Tamm, Jörg P. Halter, Jakob R. Passweg, Martina Kleber
Publikováno v:
HemaSphere, Vol 6, Iss 4, p e704 (2022)
Pretransplant risk scores such as the revised Pretransplant Assessment of Mortality (rPAM) score help to predict outcome of patients receiving allogeneic hematopoietic cell transplantation (allo-HCT). Since the rPAM has not been validated externally
Externí odkaz:
https://doaj.org/article/55051c2c8a8b4b52b16ab848842c78c3
Autor:
Beatrice Drexler, Jakob R. Passweg, Alexandar Tzankov, Martin Bigler, Alexandre PA Theocharides, Nathan Cantoni, Peter Keller, Georg Stussi, Axel Ruefer, Rudolf Benz, Geneviève Favre, Pontus Lundberg, Ronny Nienhold, Andrea Fuhrer, Christine Biaggi, Markus G. Manz, Mario Bargetzi, Simon Mendez-Ferrer, Radek C. Skoda
Publikováno v:
Haematologica, Vol 104, Iss 4 (2019)
The β-3 sympathomimetic agonist BRL37344 restored nestin-positive cells within the stem cell niche, and thereby normalized blood counts and improved myelofibrosis in a mouse model of JAK2-V617F-positive myeloproliferative neoplasms. We therefore tes
Externí odkaz:
https://doaj.org/article/8479aa021716446aad1f99447b3fef97
Autor:
Jakob R. Passweg, Helen Baldomero, Marc Ansari, Gabriela M. Baerlocher, Mario Bargetzi, Yves Chalandon, Michel A. Duchosal, Sabine Gerull, Tayfun Güngör, Jörg P. Halter, Dominik Heim, Urs Hess, Kurt Leibundgut, Stavroula Masouridi-Levrat, Antonia Müller, Gayathri Nair, Thomas Pabst, Christoph Renner, Adrian Schmidt, Georg Stussi, Grazia Nicoloso de Faveri, Urs Schanz, for the Swiss Blood Stem Cell Transplantation Group (SBST)
Publikováno v:
Swiss Medical Weekly, Vol 148, Iss 0910 (2018)
In 1997, the Swiss Blood Stem Cell Transplantation Group (SBST) initiated a mandatory national registry for all haematopoietic stem cell transplants (HCTs) in Switzerland. As of 2016, after 20 years, information was available for 7899 patients who ha
Externí odkaz:
https://doaj.org/article/c36c8bd0307b48e194437f606e771da4
Autor:
Anna M. Paczulla, Stephan Dirnhofer, Martina Konantz, Michael Medinger, Helmut R. Salih, Kathrin Rothfelder, Dimitrios A. Tsakiris, Jakob R. Passweg, Pontus Lundberg, Claudia Lengerke
Publikováno v:
Haematologica, Vol 102, Iss 5 (2017)
Repopulation of immunodeficient mice remains the primary method for functional assessment of human acute myeloid leukemia. Published data report engraftment in ~40–66% of cases, mostly of intermediate- or poor-risk subtypes. Here we report that ext
Externí odkaz:
https://doaj.org/article/b25912527f014b819d42a15bac7cd2bd
Autor:
Andrea Bacigalupo, Gerard Socié, Rose Marie Hamladji, Mahmoud Aljurf, Alexei Maschan, Slawomira Kyrcz-Krzemien, Alicja Cybicka, Henrik Sengelov, Ali Unal, Dietrich Beelen, Anna Locasciulli, Carlo Dufour, Jakob R. Passweg, Rosi Oneto, Alessio Signori, Judith C.W. Marsh, for the Aplastic Anemia Working Party of the European Group for Blood Marrow Transplantation (WPSAA-EBMT)
Publikováno v:
Haematologica, Vol 100, Iss 5 (2015)
We have analyzed 1448 patients with acquired aplastic anemia grafted between 2005 and 2009, and compared outcome of identical sibling (n=940) versus unrelated donor (n=508) transplants. When compared to the latter, sibling transplants were less likel
Externí odkaz:
https://doaj.org/article/d50d23e7cd4a43079118028ff90b09f5